I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
van Amerongen, Rosa A
17
results:
Search for persons
X
Format
Online (17)
Mediatypes
Articles (Online) (7)
OpenAccess-fulltext (10)
Sorted by: Relevance
Sorted by: Year
?
1
Human iPSC-derived preclinical models to identify toxicity ..:
van Amerongen, Rosa A.
;
Morton, Laura T.
;
Chaudhari, Umesh G.
...
Molecular Therapy - Methods & Clinical Development. 28 (2023) - p. 249-261 , 2023
Link:
https://doi.org/10.1016/..
?
2
PRAME and CTCFL-reactive TCRs for the treatment of ovarian ..:
van Amerongen, Rosa A.
;
Tuit, Sander
;
Wouters, Anne K.
...
Frontiers in Immunology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
3
WT1-specific TCRs directed against newly identified peptide..:
van Amerongen, Rosa A
;
Hagedoorn, Renate S
;
Remst, Dennis F G
...
Journal for ImmunoTherapy of Cancer. 10 (2022) 6 - p. e004409 , 2022
Link:
https://doi.org/10.1136/..
?
4
Exosomes derived from mesenchymal non-small cell lung cance..:
Lobb, Richard J.
;
van Amerongen, Rosa
;
Wiegmans, Adrian
...
International Journal of Cancer. 141 (2017) 3 - p. 614-620 , 2017
Link:
https://doi.org/10.1002/..
?
5
Oncogenic transformation of lung cells results in distinct ..:
Lobb, Richard J.
;
Hastie, Marcus L.
;
Norris, Emma L.
...
PROTEOMICS. 17 (2017) 23-24 - p. , 2017
Link:
https://doi.org/10.1002/..
?
6
Next-generation sequencing in NSCLC and melanoma patients: ..:
van Amerongen, Rosa
;
P Retèl, Valesca
;
Coupé, Veerle MH
...
ecancermedicalscience. 10 (2016) - p. , 2016
Link:
https://doi.org/10.3332/..
?
7
CD45RA, a specific marker for leukaemia stem cell sub‐popul..:
Kersten, Bas
;
Valkering, Matthijs
;
Wouters, Rolf
...
British Journal of Haematology. 173 (2016) 2 - p. 219-235 , 2016
Link:
https://doi.org/10.1111/..
?
8
PRAME and CTCFL-reactive TCRs for the treatment of ovarian ..:
van Amerongen, Rosa A
;
Tuit, Sander
;
Wouters, Anne K
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070997/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
9
Human iPSC-derived preclinical models to identify toxicity ..:
van Amerongen, Rosa A
;
Morton, Laura T
;
Chaudhari, Umesh G
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931760/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
WT1-specific TCRs directed against newly identified peptide..:
van Amerongen, Rosa A
;
Hagedoorn, Renate S
;
Remst, Dennis F G
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214430/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Table_2_PRAME and CTCFL-reactive TCRs for the treatment of ..:
Rosa A. van Amerongen
;
Sander Tuit
;
Anne K. Wouters
...
doi:10.3389/fimmu.2023.1121973.s004. , 2023
Link:
https://doi.org/10.3389/..
?
12
DataSheet_2_PRAME and CTCFL-reactive TCRs for the treatment..:
Rosa A. van Amerongen
;
Sander Tuit
;
Anne K. Wouters
...
doi:10.3389/fimmu.2023.1121973.s002. , 2023
Link:
https://doi.org/10.3389/..
?
13
PRAME and CTCFL-reactive TCRs for the treatment of ovarian ..:
Rosa A. van Amerongen
;
Sander Tuit
;
Anne K. Wouters
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1121973/full. , 2023
Link:
https://doi.org/10.3389/..
?
14
Human iPSC-derived preclinical models to identify toxicity ..:
Rosa A. van Amerongen
;
Laura T. Morton
;
Umesh G. Chaudhari
...
http://www.sciencedirect.com/science/article/pii/S2329050123000074. , 2023
Link:
https://doi.org/10.1016/..
?
15
Table_1_PRAME and CTCFL-reactive TCRs for the treatment of ..:
Rosa A. van Amerongen
;
Sander Tuit
;
Anne K. Wouters
...
doi:10.3389/fimmu.2023.1121973.s003. , 2023
Link:
https://doi.org/10.3389/..
1-15